ORIGINAL RESEARCH—ENDOCRINOLOGY: NCEP-ATPIII-Defined Metabolic Syndrome, Type 2 Diabetes Mellitus, and Prevalence of Hypogonadism in Male Patients with Sexual Dysfunction
- 31 July 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 4 (4_Part_1) , 1038-1045
Abstract
Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS) are characterized by insulin resistance and often associated with male hypogonadism. To discriminate the specific contribution of T2DM and MetS to male hypogonadism. A consecutive series of 1,134 (mean age 52.1 ± 13 years) male patients with sexual dysfunction was studied. Several hormonal and biochemical parameters were studied along with ANDROTEST, a 12-item validated structured interview, specifically designed for the screening of hypogonadism (total testosterone [TT] P < 0.0001). Conversely, T2DM was associated with a higher prevalence of hypogonadism in subjects with MetS but not in those without MetS. Patients with MetS, with or without T2DM, also showed a higher ANDROTEST score when compared with patients without MetS. Logistic multivariate regression analysis, incorporating the five components of MetS, identified a significant association of elevated waist circumference and hypertriglyceridemia with hypogonadism both in patients, with or without T2DM. Our study demonstrated that MetS, and in particular visceral adiposity (as assessed by increased waistline and hypertriglyceridemia), is specifically associated with hypogonadism in subjects consulting for sexual dysfunction. Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, Fisher AD, Lotti F, Chiarini V, Fedele D, Forti G, and Maggi M. GNCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction.Keywords
This publication has 56 references indexed in Scilit:
- Diabetes and the urologist: a growing problemBJU International, 2007
- Psychobiologic Correlates of the Metabolic Syndrome and Associated Sexual DysfunctionEuropean Urology, 2006
- Obesity, Dyslipidemias and Erectile Dysfunction: A Report of a Subcommittee of the Sexual Medicine Society of North AmericaThe Journal of Sexual Medicine, 2006
- HYPOANDROGEN‐METABOLIC SYNDROME: A SIGNIFICANT ISSUE FOR MEN’S HEALTHBJU International, 2006
- Steps by which better overall health for men could be achievedBJU International, 2006
- Sildenafil citrate (Viagra) treatment for erectile dysfunction: an updated profile of response and effectivenessInternational Journal Of Impotence Research, 2006
- The Effect of Diabetes Mellitus Treatment and Good Glycemic Control on the Erectile Function in Men with Diabetes Mellitus-Induced Erectile Dysfunction: A Pilot StudyThe Journal of Sexual Medicine, 2006
- Obesity, the metabolic syndrome, and sexual dysfunctionInternational Journal Of Impotence Research, 2005
- High Proportions of Erectile Dysfunction in Men With the Metabolic SyndromeDiabetes Care, 2005
- Organic, Relational and Psychological Factors in Erectile Dysfunction in Men with Diabetes MellitusEuropean Urology, 2004